The FDA issued updates on October 2 regarding drugs that are currently in shortage:
- Atenolol Tablets (Updated – Currently in Shortage)
- Carbidopa and Levodopa Extended Release Tablets (Updated – Currently in Shortage)
- Dexrazoxane Injection (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- L-Cysteine Hydrochloride Injection (Updated – Currently in Shortage)
- Rocuronium Bromide Injection (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (New – Currently in Shortage)
- Theophylline Extended Release Tablets and Capsules (Updated – Currently in Shortage)
- Tolmetin Sodium Tablets, USP (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
